Dean Eurich
Professor, School of Public Health, University of Alberta
Dean Eurich is a Professor in the first Canadian accredited School of Public Health at the University of Alberta. He is the Program Director for the Clinical Epidemiology program and a Research Associate with the Alliance for Canadian Health Outcomes Research in Diabetes, a member of the Alberta Diabetes Institute Research & Trainee Steering Committee at the University. Provincially, Dean is a Joint Lead, Career Development in Methods & Health Services Research platform for Alberta’s Strategy for Patient Oriented Research Support for People and Patient-Oriented Research and Trials Unit. Nationally, he is an elected Member Royal Society of Canada College of New Scholars, Artists and Scientists. He also serves as the Chair for the Personal Awards Committee and Board Member of the Diabetes Canada’s National Research Council. Dean’s research has focused largely in the areas of clinical epidemiology and health services research. Within those core areas, his research program has targeted three of the most common diseases – diabetes, heart failure, and community acquired pneumonia. Collectively, these diseases affect a large number of patients, are rapidly increasing due to our aging population, and result in significant morbidity and mortality, particularly in the elderly. Moreover, these disease states often co-exist within individual patients, placing tremendous strain on our health care system due to the high degree of health services utilization associated with their management. Within these three disease areas, Dean’s research aims to evaluate health outcomes and health services use in general using traditional epidemiological techniques and newer machine learning approaches. Given his training as a clinical pharmacist, he is particularly interested in knowledge synthesis and evaluation of the safety and effectiveness of drug therapies in real-world settings.
Dean Eurich is a Professor in the first Canadian accredited School of Public Health at the University of Alberta. He is the Program Director for the Clinical Epidemiology program and a Research Associate with the Alliance for Canadian Health Outcomes Research in Diabetes, a member of the Alberta Diabetes Institute Research & Trainee Steering Committee at the University. Provincially, Dean is a Joint Lead, Career Development in Methods & Health Services Research platform for Alberta’s Strategy for Patient Oriented Research Support for People and Patient-Oriented Research and Trials Unit. Nationally, he is an elected Member Royal Society of Canada College of New Scholars, Artists and Scientists. He also serves as the Chair for the Personal Awards Committee and Board Member of the Diabetes Canada’s National Research Council. Dean’s research has focused largely in the areas of clinical epidemiology and health services research. Within those core areas, his research program has targeted three of the most common diseases – diabetes, heart failure, and community acquired pneumonia. Collectively, these diseases affect a large number of patients, are rapidly increasing due to our aging population, and result in significant morbidity and mortality, particularly in the elderly. Moreover, these disease states often co-exist within individual patients, placing tremendous strain on our health care system due to the high degree of health services utilization associated with their management. Within these three disease areas, Dean’s research aims to evaluate health outcomes and health services use in general using traditional epidemiological techniques and newer machine learning approaches. Given his training as a clinical pharmacist, he is particularly interested in knowledge synthesis and evaluation of the safety and effectiveness of drug therapies in real-world settings.